Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Trovagene Inc (NASDAQ:TROV)

2.21
Delayed Data
As of 1:09pm ET
 -0.0366 / -1.63%
Today’s Change
1.78
Today|||52-Week Range
6.93
+5.40%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Zaniboni Stephen L
Former Chief Financial Officer
Buy4/21/201671,125$3.60$256.1K-65.12%
Tennant Stanley Neal
Director
Buy12/16/201614,966$2.00$29.9K+7.14%
Tennant Stanley Neal
Director
Buy12/19/201610,000$2.10$21.0K+7.14%
Zaniboni Stephen L
Former Chief Financial Officer
Buy4/21/20164,514$4.39$19.8K-65.12%
Erlander Mark
Chief Scientific Officer
Buy12/14/20165,000$2.08$10.4K+8.43%
Welch William J
Chief Executive Officer
Buy12/16/20162,500$2.10$5.3K+7.14%
Welch William J
Chief Executive Officer
Buy12/16/20162,250$2.09$4.7K+7.14%
Erlander Mark
Chief Scientific Officer
Buy1/02/201750,000$0.00$0.00+9.76%
Erlander Mark
Chief Scientific Officer
Sale1/02/201723,968$0.00$0.00+9.76%